{"html":"
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> Posters<\/span>
\n October 25, 2025 <\/div>\n \n <\/div>\n \n
Validating a FAP-Targeted Glioblastoma Model for Preclinical Imaging and Radioligand Therapy<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> Events<\/span>
\n 6\u20138 November 2025\n <\/div>\n \n <\/div>\n \n
Society of Nuclear Medicine and Molecular Imaging Therapeutics Conference<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> Events<\/span>
\n 6\u20139 December 2025\n <\/div>\n \n <\/div>\n \n
American Society of Hematology Annual Meeting<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> Events<\/span>
\n 6\u20138 November 2025\n <\/div>\n \n <\/div>\n \n
American Society of Nephrology Kidney Week 2025<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> Webinars<\/span>
\n October 21, 2025 <\/div>\n \n <\/div>\n \n
Imaging Excellence in Hematology Trials: From Protocol through Delivery<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> Publications<\/span>
\n October 20, 2025 <\/div>\n \n <\/div>\n \n
Translational Neuroimaging Study Reveals Mitochondrial Dysfunction in ALS<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> News<\/span>
\n October 9, 2025 <\/div>\n \n <\/div>\n \n
Perceptive Imaging Announces Leadership Succession: Doug Fulling appointed CEO to accelerate growth, enhance services, and drive innovation<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> Webinars<\/span>
\n September 30, 2025 <\/div>\n \n <\/div>\n \n
Imaging Alzheimer’s Before Symptoms Emerge: The Long, Silent Prelude<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> Blogs<\/span>
\n September 11, 2025 <\/div>\n \n <\/div>\n \n
Why Experience Matters: Choosing the Right Partner for Preclinical Radiopharmaceutical Development<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"\" <\/figure>\n <\/a>\n
\n <\/svg> Blogs<\/span>
\n September 10, 2025 <\/div>\n \n <\/div>\n \n
Imaging Challenges in Blood Disorder Clinical Trials<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"Abstract <\/figure>\n <\/a>\n
\n <\/svg>
\n September 9, 2025 <\/div>\n \n <\/div>\n \n
Perceptive Preclinical Imaging CRO reduces uncertainty in clinical translation<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n
\n \n
\n \"Abstract <\/figure>\n <\/a>\n
\n <\/svg> Article<\/span>
\n September 9, 2025 <\/div>\n \n <\/div>\n \n
De-risking CNS drug development with advanced preclinical imaging CRO solutions<\/h6>\n <\/a>\n Read more \n\n\n<\/svg>\n<\/a>\n <\/div>\n \n \n
\n
\n \n \n <\/svg> <\/a>\n\n \n
\n \n 1 <\/a>\n \n 2 <\/a>\n \n 3 <\/a>\n \n 4 <\/a>\n <\/div>\n\n \n \n <\/svg> <\/a>\n <\/div>\n <\/div>\n \n\n","total_posts_count":257}